Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

FBR 001

Drug Profile

FBR 001

Alternative Names: FBR-001; Mers-CoV (FBR-001)

Latest Information Update: 22 Jul 2016

At a glance

  • Originator Fabentech
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Research Middle East respiratory syndrome coronavirus

Most Recent Events

  • 22 Jul 2016 Early research in Middle East respiratory syndrome coronavirus (Prevention) in France (Parenteral)

Development Overview

Introduction

Fabentech is developing a vaccine against the Middle East respiratory syndrome coronavirus (MERS-CoV), designated FBR 001, in early research stage in France.

FBR 001 is a passive immunotherapy comprising administration of F(ab')2 fragments of specific equine polyclonal immunoglobulins against the Middle East respiratory syndrome coronavirus (MERS-CoV).

Key Development Milestones

Fabentech is conducting early research studies with FBR 001 in France.

Drug Properties & Chemical Synopsis

  • Route of administration Parenteral
  • Formulation unspecified
  • Class Viral vaccines
  • Mechanism of Action Immunostimulants
  • WHO ATC code

    J07B (Viral Vaccines)

  • EPhMRA code

    J7A (Pure Vaccines)

Development Status

Summary Table

Indication Qualifier Patient Segment Phase Countries Route / Formulation Developers Event Date
Middle East respiratory syndrome coronavirus - Prevention Research France Parenteral / unspecified Fabentech 22 Jul 2016

Commercial Information

Involved Organisations

Organisation Involvement Countries
Fabentech Originator France
Fabentech Owner France

Development History

Event Date Update Type Comment
22 Jul 2016 Phase Change Early research in Middle East respiratory syndrome coronavirus (Prevention) in France (Parenteral) Updated 22 Jul 2016
Back to top